Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
6Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
Surrozen, Inc. (SRZN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
2Distinct source URLs
6High confidence
0.792Average confidence
2026-07-01Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Surrozen, Inc. Suppliers
Ticker
Name
Confidence
Evidence
TCGFB
TCGFB
90%
In October 2025, the Company received a notice from TCGFB to terminate the TCGFB Collaboration effective as of November 13, 2025.
Surrozen, Inc. Customers
Ticker
Name
Confidence
Evidence
BOEHRINGER-INGELHEIM-INTERNATIONAL-GMBH
BOEHRINGER-INGELHEIM-INTERNATIONAL-GMBH
92%
The Company granted Boehringer Ingelheim an exclusive, royalty-bearing, worldwide, sublicensable license, under the applicable patents and know-how, to develop, manufacture and commercialize, for all…
TCGFB-INC
TCGFB-INC
92%
In exchange for our research services, TCGFB agreed to pay us up to $6.0 million in the aggregate, plus any third-party costs
DELAWARE-GENERAL-CORPORATION
DELAWARE-GENERAL-CORPORATION
62%
in their prescription drug and other health care programs. These measures could reduce the ultimate demand for our products, once approved, or put pressure on our product pricing. We expect that addi…
HEALTH-RESOURCES
HEALTH-RESOURCES
62%
in those countries. Approval by one regulatory authority does not ensure approval by regulatory authorities in other jurisdictions. The approval process varies from country to country, can involve ad…
NURA-BIO-INC
NURA-BIO-INC
62%
ent with the Company’s ordinary activities, the Company determined that the TCGFB Collaboration is in the scope of ASC 606 by analogy. The Company evaluated the promised goods and services and determ…
USA-LLC
USA-LLC
62%
in their prescription drug and other health care programs. These measures could reduce the ultimate demand for our products, once approved, or put pressure on our product pricing. We expect that addi…
Surrozen, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
SRZN-DEBT-12749
Warrants outstanding: 434000
90%
xbrl warrant detail from xbrl 2026-03-31.
SRZN-DEBT
Debt stack $6.8M
90%
Market cache reports total debt of $6.8M.
Surrozen, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Surrozen, Inc..
Surrozen, Inc. Ownership
Holder
Name
Confidence
Evidence
SRZN-OWNER-TCG-CROSSOVER-MANAGEMENT-LLC
TCG Crossover Management, LLC
90%
13F overlay lists TCG Crossover Management, LLC as top holder; 58 tracked holders.
Surrozen, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
